Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Halabi KC, Ross B, Acker KP, Cannon J-, Messina M, Mangino D, et al. Successful diagnostic stewardship for Clostridioides difficile testing in pediatrics. Infect Control Hosp Epidemiol. 2023;44(2):186-190.

Martinez-Ordoñez A, Duran A, Ruiz-Martinez M, Cid-Diaz T, Zhang X, Han Q, et al. Hyaluronan driven by epithelial aPKC deficiency remodels the microenvironment and creates a vulnerability in mesenchymal colorectal cancer. Cancer Cell. 2023;41(2):252-271.e9.

Nishida J, Cristea S, Bodapati S, Puleo J, Bai G, Patel A, et al. Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression. Proc Natl Acad Sci U S A. 2023;120(49):e2316763120.

Stopsack KH, Su XA, J Vaselkiv B, Graff RE, Ebot EM, Pettersson A, et al. Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS Fusions. Mol Cancer Res. 2023;21(1):14-23.

Mesa KR, O'Connor KA, Ng C, Salvatore SP, Littman DR. Niche-specific macrophage loss promotes skin capillary aging. bioRxiv. 2023.

Gould CV, Free RJ, Bhatnagar J, Soto RA, Royer TL, Maley WR, et al. Transmission of yellow fever vaccine virus through blood transfusion and organ transplantation in the USA in 2021: report of an investigation. Lancet Microbe. 2023;4(9):e711-e721.

Geng C, Zhang M-, Manyam GC, Vykoukal JV, Fahrmann JF, Peng S, et al. SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression. Clin Cancer Res. 2023;29(21):4464-4478.

Hwang JK, Magro CM, Lipner SR. Nail Unit Arteriovenous Hemangioma Presenting as Longitudinal Erythronychia. Skin Appendage Disord. 2023;9(4):300-305.

Galbraith K, Vasudevaraja V, Serrano J, Shen G, Tran I, Abdallat N, et al. Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing. Neurooncol Adv. 2023;5(1):vdad076.

Bandini C, Mereu E, Paradzik T, Labrador M, Maccagno M, Cumerlato M, et al. Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma. Exp Hematol Oncol. 2023;12(1):71.